Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Grant | Utility: Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer Filling date: 13 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Treatment with anti-PCSK9 antibodies Filling date: 13 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Aminopyrimidinyl compounds Filling date: 13 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: FGF23 c-tail fusion proteins Filling date: 13 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: GLYCOCONJUGATION PROCESS Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: CYCLIN DEPENDENT KINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: CANCER TREATMENT Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: Dosing Regimen of Avelumab for the Treatment of Cancer Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Design: Therapeutic wrap Filling date: 13 Sep 2025 Issue date: 29 Oct 2019 |
Application | Utility: IMIDAZOPYRIDAZINE COMPOUNDS Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Sulfonyl amide derivatives for the treatment of abnormal cell growth Filling date: 13 Sep 2025 Issue date: 22 Oct 2019 |
Application | Utility: Stable Liquid Antibody Formulation Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: Antibodies to MAdCAM Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Grant | Utility: Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Substituted nucleoside derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Application | Utility: HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: MEDIA AND FERMENTATION METHODS FOR PRODUCING POLYSACCHARIDES IN BACTERIAL CELL CULTURE Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Grant | Utility: Anti-CXCR4 antibodies and antibody-drug conjugates Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Heteroaromatic compounds and their use as dopamine D1 ligands Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Crystalline form of lorlatinib free base Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Application | Utility: Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Grant | Utility: Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate Filling date: 13 Sep 2025 Issue date: 17 Sep 2019 |
Application | Utility: 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: Combination of an EGFR T790M Inhibitor and a CDK Inhibitor for the Treatment of Non-Small Cell Lung Cancer Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: Cycloalkyl-Linked Diheterocycle Derivatives Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: Bicyclic-Fused Heteroaryl or Aryl Compounds Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: Methods of Controlling Morphology of Polymeric Nanoparticles Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: Cyclic Peptides As C5a Receptor Antagonists Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: IL-15 Variants and Uses Thereof Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Grant | Utility: Bifunctional cytotoxic agents Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Bispecific antibodies Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof Filling date: 13 Sep 2025 Issue date: 20 Aug 2019 |
Application | Utility: Tetrahydroquinazoline Derivatives Useful as Anticancer Agents Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Grant | Utility: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Filling date: 13 Sep 2025 Issue date: 13 Aug 2019 |
Application | Utility: CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: CHIMERIC ANTIGEN RECEPTORS TARGETING CD70 Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: Substituted Quinazoline and Pyridopyrimidine Derivatives Useful as Anticancer Agents Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Showing 400 to 450 of 451 patents.